DHJJ Financial Advisors’s Gilead Sciences GILD Stock Holding History

DHJJ Financial Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$37.4K	Buy	296 +1	+0.3%	+$132	0.01%	459
2026 Q1	$41.2K	Hold	295	–	–	0.01%	435
2025 Q4	$36.2K	Hold	295	–	–	0.01%	427
2025 Q3	$32.7K	Buy	295 +18	+6%	+$2.05K	0.01%	423
2025 Q2	$30.8K	Buy	277 +54	+24%	+$5.75K	0.01%	416
2025 Q1	$25K	Hold	223	–	–	0.01%	406
2024 Q4	$20.6K	Hold	223	–	–	0.01%	413
2024 Q3	$18.7K	Hold	223	–	–	0.01%	417
2024 Q2	$15.3K	Hold	223	–	–	0.01%	406
2024 Q1	$16.3K	Hold	223	–	–	0.01%	386
2023 Q4	$18.1K	Hold	223	–	–	0.01%	369
2023 Q3	$16.7K	Buy	+223	New	+$17.2K	0.01%	377

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

DHJJ Financial Advisors's GILD Position: Q2 2026 in Review

DHJJ Financial Advisors increased its Gilead Sciences (GILD) stake by 0.34% in Q2 2026, buying an estimated $132 and bringing the position to 296 shares worth $37.4K. The position accounts for 0.01% of the portfolio, ranked #459.

DHJJ Financial Advisors first reported a position in GILD in Q3 2023 and has held it in 12 quarters since. The position peaked at $41.2K in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

DHJJ Financial Advisors held 296 shares of Gilead Sciences worth $37.4K as of Q2 2026.
DHJJ Financial Advisors bought 1 Gilead Sciences share in Q2 2026, an estimated $132.
Gilead Sciences made up 0.01% of DHJJ Financial Advisors's portfolio in Q2 2026, its #459 holding.
DHJJ Financial Advisors first reported a position in Gilead Sciences in Q3 2023 and has held it in 12 quarters since.
DHJJ Financial Advisors's Gilead Sciences position peaked at $41.2K in Q1 2026.
690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on DHJJ Financial Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.